Teva, Intel to develop wearables to monitor Huntington's disease : reuters

as informed in reuters

Teva, Intel to develop wearables to monitor Huntington's disease

Teva, Intel to develop wearables to monitor Huntington's disease

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011.REUTERS/Ronen ZvulunTeva Pharmaceutical Industries Ltd (TEVA.TA) said on Thursday it was collaborating with Intel Corp (INTC.O) to develop a wearable device to monitor patients with Huntington's, a fatal degenerative disease.The inherited disorder causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition and mental stability.There are no approved drugs to alter the course of Huntington's, although there are medicines that help with symptoms.


coupled with timesofisrael

Teva, Intel join forces to monitor Huntington disease

Teva, Intel join forces to monitor Huntington disease

Teva Pharmaceutical Industries Ltd. said Thursday it would collaborate with Intel Corp. to develop a wearable device combined with a machine learning platform to try and improve treatment for Huntington's disease.The jointly developed platform will continuously monitor and analyze key symptoms that impact the daily lives of patients with Huntington's in an effort to better understand the progression of the disease and the impact of treatment on patients, Teva said in a statement.Huntington's, a fatal and neurodegenerative disease, is a devastating illness that urgently requires new treatment options, the statement said, including ways to continuously and remotely assess and quantify symptoms that can give useful and actionable feedback to doctors, patients and caregivers.The disease is characterized by uncoordinated and uncontrollable movements, cognitive deterioration and behavioral and/or psychological problems.


in the same way reuters

Teva, Intel to develop wearables to monitor Huntington's disease

Teva, Intel to develop wearables to monitor Huntington's disease

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011.REUTERS/Ronen ZvulunTeva Pharmaceutical Industries Ltd (TEVA.TA) said on Thursday it was collaborating with Intel Corp (INTC.O) to develop a wearable device to monitor patients with Huntington's, a fatal degenerative disease.The inherited disorder causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition and mental stability.There are no approved drugs to alter the course of Huntington's, although there are medicines that help with symptoms.